We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCL icon
1226
Stepan Co
SCL
$1.32B
$4K ﹤0.01%
34
-12
-26% -$1.57K
BNT
1227
Brookfield Wealth Solutions
BNT
$11.7B
$4K ﹤0.01%
+110
New +$4.18K
ARD
1228
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$4K ﹤0.01%
153
NNOX icon
1229
Nano X Imaging
NNOX
$64.7M
$3K ﹤0.01%
98
ABEV icon
1230
Ambev
ABEV
$46.8B
-25,915
Closed -$71K
ACAD icon
1231
Acadia Pharmaceuticals
ACAD
$4.34B
-2,882
Closed -$74K
ADVM
1232
DELISTED
Adverum Biotechnologies
ADVM
-570
Closed -$56K
AGEN
1233
Agenus
AGEN
$247M
-777
Closed -$41K
AGIO icon
1234
Agios Pharmaceuticals
AGIO
$2.26B
-1,504
Closed -$78K
AIT icon
1235
Applied Industrial Technologies
AIT
$12.8B
-37,460
Closed -$3.42M
AKBA icon
1236
Akebia Therapeutics
AKBA
$338M
-21,604
Closed -$73K
AKRO
1237
DELISTED
Akero Therapeutics
AKRO
-1,034
Closed -$30K
ALDX icon
1238
Aldeyra Therapeutics
ALDX
$94.1M
-3,810
Closed -$45K
ALEC icon
1239
Alector
ALEC
$170M
-2,918
Closed -$59K
ALG icon
1240
Alamo Group
ALG
$2.01B
-11,188
Closed -$1.75M
ALKS icon
1241
Alkermes
ALKS
$8.9B
-4,014
Closed -$75K
ALLK
1242
DELISTED
Allakos
ALLK
-633
Closed -$73K
ALLO icon
1243
Allogene Therapeutics
ALLO
$635M
-2,028
Closed -$72K
ALNY icon
1244
Alnylam Pharmaceuticals
ALNY
$37.6B
-550
Closed -$78K
ALSN icon
1245
Allison Transmission
ALSN
$10B
-20,682
Closed -$844K
ALT icon
1246
Altimmune
ALT
$556M
-4,650
Closed -$66K
ALXO icon
1247
ALX Oncology
ALXO
$277M
-1,010
Closed -$74K
ANAB icon
1248
AnaptysBio
ANAB
$1.61B
-2,122
Closed -$46K
ANIK icon
1249
Anika Therapeutics
ANIK
$199M
-645
Closed -$26K
ANNX icon
1250
Annexon
ANNX
$865M
-558
Closed -$16K

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.